2020 Antibody Biology & Engineering Gordon Research Conference and Gordon Research Seminar

2020年抗体生物学

• 批准号: 9913160
• 负责人: Jeanette Leusen
• 金额: $ 0.8万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-02-05 至 2023-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9913160
• 关键词: Academia; Address; Antibodies; Area; Autoimmune Diseases; Autoimmunity; B-Cell Activation; B-Lymphocytes; Basic Science; Biological; Biological Products; Biology; Cells; Clinic; Clinical; Clinical Trials; Collaborations; Communicable Diseases; Communities; Development; Disease; Elements; Engineering; Ensure; Evaluation; Fc Receptor; Future; Immune; Immunity; Immunoglobulins; Industrialization; Industry; Infection; Inflammation; Inflammatory; Influentials; International; Investigation; Malignant Neoplasms; Mediating; Mentors; Mentorship; Monoclonal Antibodies; Oncology; Oral; Participant; Pharmacologic Substance; Postdoctoral Fellow; Recording of previous events; Reporting; Research; Research Activity; Research Personnel; Role; Running; Scientist; Series; Structure; System; Therapeutic; Therapeutic Intervention; Therapeutic antibodies; Time; Work; antibody engineering; base; cancer immunotherapy; career; clinical application; clinical practice; clinically significant; collaborative environment; design; drug candidate; graduate student; immunoglobulin structure; informal atmosphere; insight; meetings; novel therapeutics; peer; posters; pre-clinical; programs; protective effect; receptor; response; supportive environment; symposium

Project Description This application seeks partial support for the 2020 Gordon Research Conference (GRC) on Antibody Biology and Engineering, together with an accompanying Gordon Research Seminar (GRS) to be held on March 15- 20, 2020 at the Ventura Beach Marriott, CA, USA. This is the 6th GRC and the 4rthGRS on this topic which is representative of a highly exciting and influential meeting in the community. The aim of this meeting is to provide in-depth coverage of important recent developments in the rapidly evolving field of antibody biology and engineering, in an informal setting designed for maximal discussion and interaction. This field has broad implications for a wide variety of biologic and clinically significant topics that cut broadly across the multiple fields within the biomedical community, including immunity, infectious diseases, inflammation and oncology. Furthermore, for the fourth time in this meeting series, we will incorporate a Gordon Research Seminar (GRS). This has proved to be a highly successful addition to the Gordon Research Conference (GRC). The GRS will run immediately prior to the GRC. It will provide seminar and poster sessions specifically for graduate students, post-doctoral fellows, and early career scientists to allow them to present and discuss their research. As before, a GRS keynote speaker together with the GRC chairs, will offer support and advice through a mentorship session and continuous interactions with the trainees during the course of the GRS and subsequent GRC meeting. The GRC will host approximately 28-30 talks from invited speakers, spanning topics in basic research through clinical applications with a very dynamic mix of scientists from academia and industry. It is envisioned, that an additional 10-14 shorter talks will be given primarily by young scientists, selected from submitted abstracts. In addition, the GRC will also incorporate 4 poster sessions. Taken together, the 2020 GRC will report the most significant recent research advances in an international field of antibody biology and engineering. The discoveries presented this conference are at the leading edge in the therapeutic antibody development and clinical applications. Building on the long history of creative academia-industry interactions which have characterized the three previous meetings in this series, this GRC and its associated GRS will provide an ideal opportunity for academic and bio-pharma researchers from around the world to network and forge new collaborations. We envision that novel therapeutic applications are likely to ensue from the cross pollination of the ideas that will be presented at this meeting. Furthermore, by providing opportunities for younger researchers to present their studies and to discuss their work with more established scientists, this meeting will act as an important spring board for the development of a future group of investigators in this rapidly emerging and critically important field. 1|Page

项目描述 该申请寻求抗体生物学的2020年戈登研究会议（GRC）的部分支持 和工程，以及将于3月15日举行的伴随的戈登研究研讨会（GRS） 20，2020在美国加利福尼亚州的文图拉海滩万豪酒店。这是第六个GRC和该主题的第4个GRC， 代表社区中一次非常激动人心和有影响力的会议。这次会议的目的是 在抗体生物学快速发展的领域的最新进展中提供深入的覆盖范围 和工程，在非正式环境中，旨在最大程度地讨论和互动。这个领域的广泛 对各种各样的生物学和临床上重要主题的影响 生物医学界的领域，包括免疫，传染病，炎症和肿瘤学。 此外，在这个会议系列的第四次，我们将融合戈登研究研讨会（GRS）。 事实证明，这是戈登研究会议（GRC）的非常成功的补充。 GRS会 在GRC之前立即运行。它将为研究生提供专门的研讨会和海报会议， 博士后研究员和早期的职业科学家可以允许他们介绍和讨论他们的研究。作为 以前，GRS主题演讲者和GRC椅子将通过 在GRS过程中，指导会议和与受训者的持续互动 随后的GRC会议。 GRC将举办大约28-30次来自受邀演讲者的演讲，通过 临床应用，具有来自学术界和工业的科学家的非常动态的组合。可以预见的是 从提交的摘要中选出的年轻科学家将主要由年轻科学家进行其他10-14次较短的谈判。在 此外，GRC还将包含4个海报会议。 综上所述，2020年GRC将报告国际上最重大的研究进展 抗体生物学和工程领域。介绍的这次会议的发现处于领先地位 治疗性抗体开发和临床应用。建立在创意的悠久历史的基础上 学术界互动是本系列中以前的三个会议的特征 它的相关GRS将为学术和生物制药研究人员提供理想的机会 在世界各地建立新的合作。我们设想新颖的治疗应用是 可能会从本次会议上提出的思想的交叉授粉中得出。此外，由 为年轻的研究人员提供机会提供研究，并与更多 既定的科学家，这次会议将充当未来小组发展的重要春季董事会 在这个迅速出现和至关重要的领域中的研究人员。 1 |页